SIGA

SIGA Technologies Inc

Healthcare Drug Manufacturers - Specialty & Generic

Portfolio

Watchlist

3.175 USD 0.04 ( 1.44%)

Last update at 2026-11-11T15:15:00Z

VOLUME

79136

Market Cap

504.12M

P/E

6.03

Momentum Score

…

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range

3.10

Low

3.24

High

52 Week Price Range

3.97

Low

12.83

High

Momentum Score

…

Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close

3.13

Dividend Yield

Revenue TTM

173.73M

Revenue Per Share

2.44

Gross Profit TTM

77.82M

Debt / Equity

0.01

ROE

58.39%

Net Debt

-148.68M

ROCE

21.27%

Diluted EPS TTM

1.17

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31
Income before tax	44.13M	89.31M	73.51M	-10.18M	411.64M
Net income	33.90M	69.45M	56.34M	-7.24M	421.81M
Selling general administrative	35.12M	17.32M	14.00M	13.25M	12.88M
Gross profit	77.82M	107.13M	99.22M	11.66M	368.77M
Reconciled depreciation	0.52M	0.52M	0.53M	0.53M	0.07M
Ebit	42.70M	89.09M	84.50M	0.50M	434.04M
Ebitda	43.73M	89.72M	85.56M	1.03M	434.11M
Depreciation and amortization	1.03M	0.62M	1.06M	0.53M	0.07M
Non operating income net other	1.43M	0.22M	-7.98M	2.82M	78.94M
Operating income	42.70M	89.09M	84.50M	0.50M	355.10M
Other operating expenses	68.08M	44.58M	40.46M	29.06M	121.95M
Interest expense	-0.92M	0.12M	3.02M	15.77M	15.48M
Tax provision	10.23M	19.86M	17.17M	-2.94M	-10.17M
Interest income	-	-	-	10.68M	22.40M
Net interest income	0.00M	0.00M	-3.02M	-15.77M	-15.48M
Income tax expense	10.23M	19.86M	17.17M	-2.94M	-10.17M
Total revenue	110.78M	133.67M	124.96M	26.74M	477.05M
Total operating expenses	35.12M	18.03M	14.72M	13.98M	13.67M
Cost of revenue	32.96M	26.54M	25.74M	15.09M	108.29M
Total other income expense net	1.43M	0.22M	-10.99M	-10.68M	72.02M
Net income from continuing ops	33.90M	69.45M	56.34M	-7.24M	421.81M
Net income applicable to common shares	33.90M	69.45M	56.34M	-7.24M	421.81M

Breakdown	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31
Total assets	254.84M	195.04M	214.73M	149.83M	198.57M
Other current assets	3.50M	2.32M	2.45M	2.11M	100.97M
Total liab	57.98M	24.88M	40.41M	20.04M	100.78M
Total stockholder equity	196.86M	170.16M	174.31M	129.79M	97.78M
Other current liab	31.31M	7.05M	24.23M	5.47M	5.92M
Common stock	0.01M	0.01M	0.01M	0.01M	0.01M
Capital stock	0.01M	0.01M	0.01M	0.01M	0.01M
Retained earnings	-38.94M	-63.80M	-51.76M	-95.19M	-123.03M
Other liab	-	2.39M	7.79M	7.66M	9.05M
Good will	0.90M	0.90M	0.90M	0.90M	0.90M
Other assets	-	6.50M	214.73M	3.22M	15.01M
Cash	150.15M	98.79M	103.14M	117.89M	65.25M
Total current liabilities	54.12M	21.52M	30.49M	10.48M	91.74M
Current deferred revenue	20.79M	10.58M	3.76M	3.28M	2.30M
Net debt	-148.68M	-98.26M	-102.67M	-117.44M	15.22M
Short term debt	0.56M	0.53M	0.47M	0.45M	80.46M
Short long term debt	-	-	-	-	80.04M
Short long term debt total	1.46M	0.53M	0.47M	0.45M	80.46M
Other stockholder equity	235.80M	233.96M	226.07M	224.98M	220.81M
Property plant equipment	-	1.85M	2.37M	2.10M	2.62M
Total current assets	238.99M	185.79M	208.75M	143.61M	180.04M
Net tangible assets	-	170.16M	173.42M	128.89M	96.89M
Net receivables	21.13M	45.41M	83.65M	3.34M	4.17M
Inventory	64.22M	39.27M	19.51M	20.27M	9.65M
Accounts payable	1.46M	3.36M	2.03M	1.28M	3.05M
Accumulated other comprehensive income	0.00M	-	-	-	-3.73M
Common stock total equity	-	0.01M	0.01M	0.01M	0.01M
Retained earnings total equity	-	-63.80M	-51.76M	-95.19M	-123.03M
Non currrent assets other	2.08M	0.25M	0.29M	0.68M	0.86M
Deferred long term asset charges	-	-	-	-	14.15M
Non current assets total	15.85M	9.25M	5.97M	6.22M	18.52M
Capital lease obligations	0.56M	0.53M	0.47M	0.45M	0.42M

Breakdown	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31
Investments	0.00M	-0.05M	-0.02M	-0.03M	78.24M
Change to liabilities	-9.01M	19.76M	-1.22M	-0.92M	5.52M
Total cashflows from investing activities	-	-0.05M	-0.02M	-0.03M	78.24M
Net borrowings	-	-	-85.91M	-85.91M	-85.91M
Total cash from financing activities	-45.96M	-26.20M	-114.60M	-1.18M	-3.81M
Change to operating activities	0.17M	0.05M	0.70M	-0.71M	-2.58M
Net income	33.90M	69.45M	56.34M	-7.24M	421.81M
Change in cash	-4.35M	-14.75M	-43.10M	-19.41M	143.30M
Begin period cash flow	103.14M	117.89M	160.99M	180.40M	37.10M
End period cash flow	98.79M	103.14M	117.89M	160.99M	180.40M
Total cash from operating activities	41.61M	11.49M	71.52M	-18.20M	68.87M
Issuance of capital stock	-	-	-	-	0.00M
Depreciation	0.52M	0.52M	0.53M	0.53M	0.07M
Other cashflows from investing activities	-	-	-	-	78.34M
Dividends paid	-32.94M	32.94M	32.94M	32.94M	-
Change to inventory	-19.96M	0.14M	-8.01M	-6.74M	0.00M
Change to account receivables	38.24M	-80.31M	0.83M	-2.21M	-0.05M
Sale purchase of stock	-13.01M	-26.02M	-28.50M	-	0.26M
Other cashflows from financing activities	-0.01M	-0.17M	-0.18M	-1.18M	-3.81M
Change to netincome	-2.05M	1.39M	18.83M	-0.30M	-7.03M
Capital expenditures	0.00M	0.05M	0.02M	0.03M	0.10M
Change receivables	38.24M	-80.31M	0.83M	-2.21M	-0.05M
Cash flows other operating	-0.03M	0.55M	4.22M	-1.31M	-351.45M
Cash and cash equivalents changes	-4.35M	-14.75M	-43.10M	-19.41M	143.30M
Change in working capital	9.44M	-60.37M	-7.70M	-10.59M	2.89M
Stock based compensation	1.78M	1.27M	1.35M	2.11M	2.27M
Other non cash items	-0.20M	0.50M	9.39M	-0.59M	-348.87M
Free cash flow	41.61M	11.44M	71.50M	-18.23M	68.77M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name	Change (USD)	Price (USD)	Trailing PE (x)	Forward PE (x)	Price Sales TTM (x)	Price to Book Value (x)	Enterprise Value to Revenue (x)	Enterprise Value to EBITDA (x)
SIGA SIGA Technologies Inc	0.04 1.44%	3.17	6.03	4.97	2.56	2.62	1.99	3.29
MKKGY Merck KGaA ADR	0.06 0.18%	33.73	21.25	14.93	3.10	2.14	3.60	12.98
MKGAF MERCK Kommanditgesellschaft auf Aktien	- -%	169.12	24.86	15.11	3.13	1.98	3.08	18.89
TAK Takeda Pharmaceutical Co Ltd ADR	-0.17 0.81%	20.76	-	10.96	0.01	1.20	2.94	23.11
TKPHF Takeda Pharmaceutical Co. Ltd.	- -%	41.72	-	10.66	0.01	1.16	2.94	23.11

Profile*

SIGA Technologies Inc

Address

31 East 62nd Street, New York, NY, United States, 10065

Contact

212 672 9100

Website

https://www.siga.com

Employees

Name	Title	Year Born
Dr. Phillip Louis Gomez III, M.D., Ph.D.	CEO & Director	1967
Mr. Daniel J. Luckshire	Exec. VP, CFO & Sec.	1971
Dr. Dennis E. Hruby	Exec. VP & Chief Scientific Officer	1952
Ms. Tove C. Bolken	Sr. VP of Operations & Chief Supply Chain Officer	NA
Mr. Herb Vloedman	Sr. VP & Chief Information Officer	NA
Mr. Daniel J. Luckshire	Executive VP, CFO & Secretary	1971
Dr. Dennis E. Hruby	Executive VP & Chief Scientific Officer	1952
Dr. Jay K. Varma M.D.	Executive VP, Chief Medical Officer & Director	1972
Dr. Diem Nguyen M.B.A., Ph.D.	CEO & Director	1973
Ms. Tove C. Bolken	Senior VP of Operations & Chief Supply Chain Officer	NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

Top Gainers*
Top Losers*

Equity Sectors*

Basic Materials

-1.70%
Communication Services

+0.33%
Consumer Cyclical

+0.45%
Consumer Defensive

-0.56%
Energy

-0.25%
Financial Services

+0.49%
Healthcare

+0.20%
Industrials

+0.74%
Real Estate

+1.71%
Technology

-2.81%
Utilities

+0.28%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

TYT	GBX 3102.38 +3.03%
CPG	GBX 33.81 -1.11%
DGED	GBX 93.25 -1.26%
LTOD	GBX 37.75 -1.44%
KNM	GBX 24500.00 +2.04%

DAR	GBX 8.30 +23.42%
VTY	GBX 276.20 +8.23%
GTCO	GBX 0.09 +6.98%
GLV	GBX 2.34 +6.36%
BUR	GBX 249.20 +5.95%

TMI	GBX 0.72 -6.49%
HSBA	GBX 1291.40 -5.42%
RKT	GBX 5218.00 -4.85%
TGA	GBX 643.00 -4.03%
RKH	GBX 61.70 -3.89%